China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.1 (HKD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22013 Q42013 Q32013 Q22012 Q4
Operating Activities:
Net Income 2,822.631,206.3723,038.061,122.3663,025.0461,330.7832,438.106719.9322,577.194251.0493,035.371,727.9762,249.6271,672.5891,810.4471,185.3411,636.069568.4122,281.664712.519661.4851,322.97661.485659.8791,319.759659.879
Depreciation & Amortization 1,764.1611,767.9291,715.6951,549.3351,602.8151,456.8691,365.0211,240.6321,203.4211,240.2621,124.585739.417777.986663.036788.679507.598675.311677.941589.529336.462338.201676.402338.201298.924597.849298.924
Deferred Income Tax 00-16,295.9746,097.982-13,813.5633,443.35200000000000000000000
Stock Based Compensation 075.24980.963101.78501.43400000000000000000000
Change In Working Capital -10,303.53413,722.868-13,283.1889,973.623-10,908.4218,299.831-7,999.5132,647.567-6,410.0647,715.428-9,727.2614,689.306-8,030.4992,885.06-8,145.567-6,975.535-6,267.5031,077.302-7,453.691-553.15-909.722-1,819.445-909.722-924.743-1,849.485-924.743
Accounts Receivables -16,173.22712,482.797-19,352.7577,428.82-15,451.566,658.26-11,855.891-1,572.237-3,548.4594,823.812-12,410.7543,442.343-6,813.022,285.668-6,799.921-3,364.083-5,372.4381,837.557-8,056.3460000000
Change In Inventory -5,582.0381,511.282-4,452.823-1,854.458-781.198-945.874-2,464.8381,487.925-2,293.472356.929-894.4031,246.963-1,217.479599.392-1,345.646-3,611.452-895.065-760.255602.655-39.4-945.884-1,891.767-945.884-273.751-547.503-273.751
Change In Accounts Payables 10,931.316011,021.9593,727.6225,635.695646.1386,890.412,876.621-1,335.5952,358.7393,830.86000000-88.172513.750000000
Other Working Capital 520.415-271.212-499.567671.639-311.3581,941.307-569.194-144.742767.462175.948-252.96400000000-513.7536.16172.32336.161-650.991-1,301.983-650.991
Other Non Cash Items 3,805.3674,615.85119,245.693-3,581.41215,714.741-1,218.63312,263.5472,028.92411,542.893-4,104.10412,383.2394,439.941,653.2124,513.989669.3058,790.6714,567.6953,159.8835,087.751,001.367956.7171,913.434956.717991.4781,982.957991.478
Operating Cash Flow -1,911.37621,388.269-5,498.75115,267.226-4,368.51213,313.636-2,093.26,948.1-670.92410,161.591-4,907.53411,596.639-3,349.6749,734.674-4,877.1363,508.075611.5725,483.538505.2521,497.1981,046.6812,093.3611,046.6811,025.5392,051.0791,025.539
Investing Activities:
Investments In Property Plant And Equipment -1,140.965-1,499.152-1,417.324-1,727.013-1,629.312-1,958.011-944.856-1,431.071-787.428-1,219.803-820.709-635.262-881.384-408.305-1,158.407-1,053.257-665.177-1,391.77-431.419-9.97-0.597-1.194-0.5972.3244.6472.324
Acquisitions Net 1,977.583-1,035.51,402.475-1,369.215797.059-930.079-81.001-227.001144.047-251.3381,286.283000000-707.837186.2450000000
Purchases Of Investments -71.5380-8,986.88512,914.815-15,962.36612,175.693-13,269.46325,865.285-26,236.73320,729.771-22,332.871000000-3,878.251-4,156.51-4,156.51-3,764.587-7,529.174-3,764.587-1,080.356-2,160.712-1,080.356
Sales Maturities Of Investments 15,826.622010,826.071-15,349.25515,365.589-11,802.57511,802.912-22,727.79823,264.24-22,416.3522,546.5760000004,586.0883,970.2653,970.2652,737.3935,474.7862,737.393731.2931,462.585731.293
Other Investing Activites -18,834.004-44.55553.7253,610.93850.374-3,840.49915.209104.21710.5613,506.73813.522-7,186.061-1,098.295-3,976.329-2,968.526-472.879238.253-5,146.4582,528.833196.2151,027.7912,055.5821,027.791346.74693.48346.74
Investing Cash Flow -2,242.302-2,579.2071,878.062-1,919.73-1,378.656-6,355.471-2,477.1991,583.632-3,605.313349.018692.801-7,821.323-1,979.679-4,384.634-4,126.933-1,526.136-426.924-5,830.3911,911.169-327.292-1,086.092-2,172.184-1,086.092150.769301.537150.769
Financing Activities:
Debt Repayment 5,859.29800-14,060.0669,004.46-4,690.2070-9,994.1766,598.19300000000000000000
Common Stock Issued 0003,358.440-370.90102,820.720000000003,765.312000001,320.5042,641.0071,320.504
Common Stock Repurchased -82.21700-150.705-332.739-86.761020.941-166.37600000000000000000
Dividends Paid 0-968.0810-942.3770-0-753.902-691.0760-0-816.986-0.011-691.286-0.009-565.59700000000000
Other Financing Activities -4,501.565-15,100.05612,747.542-4,893.837-2,078.649-1,032.01611,875.9781,332.716-1,689.783-11,455.5663,169.2981,731.4483,627.292-5,759.819,452.2871,902.037-2,527.495888-2,442.283-11,596.6619,563.231-19,242.556-9,621.2785,617.024-11,794.783-5,897.391
Financing Cash Flow 1,275.516-16,068.13612,747.542-16,688.5457,686.944-5,808.98411,122.076-9,331.5955,730.41-11,455.5662,352.3121,731.4372,936.006-5,759.8198,886.691,902.037-2,527.495888-2,442.283-11,596.661-9,621.278-19,242.556-9,621.278-5,897.391-11,794.783-5,897.391
Other Information:
Effect Of Forex Changes On Cash 0750.6-741.002840.431-803.426-625.698263.009-1,133.489279.682-223.362-4.712-530.945-120.858283.272446.368-406.309-377.514-1,048.51912.23610,296.5069,300.82918,601.6579,300.8295,341.52410,683.0485,341.524
Net Change In Cash -2,311.3193,491.5268,276.253-1,839.865630.1671,162.7916,441.547-544.6881,129.488-1,056.072-1,867.1334,975.808-2,514.205-126.507328.9893,477.667-2,720.361-10,229.25510,288.332-130.25-359.861-359.861-359.861620.441620.441620.441
Cash At End Of Period 30,083.00127,423.18432,394.3224,118.06725,957.93225,327.76524,164.97417,723.42718,268.11517,138.62718,194.69916,636.33711,660.52914,174.73414,301.24113,972.25210,494.5853,493.06313,722.3183,303.7373,433.9863,433.9863,433.9863,793.8473,793.8473,793.847